Complete remission of refractory hepatoblastoma after liver transplantation in a child with sorafenib monotherapy: A new hope?

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26701. Epub 2017 Jul 11.

Authors

Naresh Shanmugam¹, Joseph J Valamparampil¹, Julius Xavier Scott², Mukul Vij¹, Gomathy Narasimhan¹, Mettu Srinivas Reddy¹, Mohamed Rela¹

Affiliations

¹ Institute of Liver Disease and Transplantation, Gleneagles Global Health City, Chennai, India.
² Department of Pediatric Hemato-oncology, Gleneagles Global Health City, Chennai, India.

PMID: 28696063
DOI: 10.1002/pbc.26701

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents / therapeutic use*
Child
Female
Hepatoblastoma / drug therapy*
Humans
Liver Neoplasms / drug therapy*
Remission Induction*
Sorafenib / therapeutic use*
Treatment Outcome

Substances

Antineoplastic Agents
Sorafenib